CLDI (Calidi Bio) Earnings per share growth rate in current year
Calidi Biotherapeutics R&D efficiency relies on precision cryogenic stem cell logistics. The YoY earnings per share growth rate on this GURU.Markets chart reflects a trend where the value 0.00 describes the current level. Humanitarian medical protection protocols guarantee business stability, while management focuses on creating unique viral cancer therapy methods.
Financial and market metric breakdowns for calidibio.com (CLDI)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
Debt to Equity Calidi Biotherapeutics|CLDI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Calidi Biotherapeutics, Inc.|CLDI - Company Aggregate Debts|Debt to Book Value Ratio Calidi Biotherapeutics|CLDI - Company Long-Term Debts|Short-Term Debt Volume Calidi Biotherapeutics|Intermediate Coverage Ratio calidibio.com
- net income and valuation ratios data:
CLDI - Net Profit|Expected Profit Calidi Biotherapeutics|CLDI - P/E Multiple|Market Cap to Projected Earnings Calidi Biotherapeutics, Inc.|CLDI - Price/Earnings to Growth Ratio|Company Value to EBITDA Calidi Biotherapeutics|CLDI - Operating profit before deduction of amortization|Earnings per share for the last four quarters Calidi Biotherapeutics|CLDI - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months calidibio.com|CLDI - Earnings growth in current year|Expected net earnings per share growth next year Calidi Biotherapeutics
Fundamental valuation:Calidi Bio
The resilience of Calidi Biotherapeutics (CLDI) is determined by its effectiveness in attracting investment for the development of oncolytic therapies. By analyzing annual EPS fluctuations, an investor can see the impact of clinical trial costs on net income. This metric calculates the percentage change in earnings per share relative to the previous year, allowing for an assessment of capital growth or contraction rates to determine the asset's fair value.
Direct competitors
BeiGene Ltd. - Earnings per share increase in current year|HALO (Halozyme Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Revolution Medicines Corp RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year cgoncology.com CGON|Earnings growth in current year URGN (UroGen Pharma)|Earnings growth in current year Bicara Therapeutics Inc BCAX|PSNL - Earnings per share growth in current year|ERAS: Earnings per share growth in current year|DCTH: Earnings growth in current year|YMAB - Expected net earnings per share growth this year|AURA (Aura Biosciences) - Earnings growth in current year|Earnings per share growth this year CADL (Candel)|Earnings growth in current year ARAY|Expected net earnings per share growth this year sellaslifesciences.com|Actuate Therapeutics, Inc. - Net earnings per share growth this year|Earnings per share increase in current year CTOR|TuHURA - Earnings growth in current year|TARA: Earnings per share growth in current year|FATE: Earnings growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year TScan Therapeutics Inc|Earnings per share growth rate in current year Champions Oncology Corp CSBR|Net earnings per share growth this year XBIT (XBiotech Inc.)|Net earnings per one share growth for the current year CVM|Earnings growth in current year OSTX (OS Therapies Inc)|Earnings per share increase in current year RADX|Artiva - Earnings growth in current year|Earnings per share growth rate in current year Adlai Nortye Ltd.|Veru (VERU) - Earnings per share growth in current year|Tempest Therapeutics Inc - Earnings per share increase in current year|XLO (Xilio Therapeutics Inc) - Earnings growth in current year|Earnings growth in current year Enochian BioSciences|Earnings per share growth in current year Mural Oncology plc (MURA)|KAPA: Earnings per share trend in current year|Earnings growth in current year OKUR (OnKure Therapeutics)|CytoMed Therapeutics Ltd (GDTC) - Earnings per share growth rate in current year|CRIS: Net earnings per share growth this year|APLM - Earnings growth in current year|THAR (Tharimmune, Inc.) - Net earnings per share growth this year|ADVB: Net earnings per one share growth for the current year|GNPX (Genprex) - Earnings growth in current year|sunshinebiopharma.com (SBFM) - Expected net earnings per share growth this year|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharma SLRX|Earnings per share growth in current year Purple Biotech PPBT|Expected net earnings per share growth this year American Oncology Network Inc (AONC)|BeiGene - Earnings growth in current year|Checkpoint Therapeutics Inc. (CKPT) - Net earnings per share growth this year|Elevation Oncology (ELEV) - Earnings per share growth in current year|ICAD (iCAD) - Earnings per share growth in current year|IKNA (Ikena Oncology Inc.) - Earnings growth in current year|Earnings per share growth this year NTBL (notablelabs.com)|Earnings growth in current year VIRX|Expected net earnings per share growth this year MorphoSys Inc|Earnings growth in current year NAYA (NAYA Bio)|AAPGV - Net earnings per share growth this year
